Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.

Published

Journal Article

We report a case of histologically proven primary leiomyoma of the liver that was evaluated with multiphasic 64-section computed tomography (CT) and gadobenate dimeglumine-enhanced magnetic resonance (MR) imaging. This lesion showed vivid enhancement during the arterial phase with sustained enhancement during the hepatic venous and equilibrium phases. During the liver-specific MR imaging phase (150 minutes after contrast injection), the same lesion demonstrated lack of contrast retention, thus appearing hypointense compared with the background liver. Because of this latter finding, the patient underwent partial resection of the liver. In primary hepatic leiomyoma, the absence of contrast uptake during the liver-specific phase of gadobenate dimeglumine-enhanced MR imaging may be inappropriately interpreted as a sign of malignancy, thus leading to unnecessary, aggressive management of such lesions.

Full Text

Duke Authors

Cited Authors

  • Marin, D; Catalano, C; Rossi, M; Guerrisi, A; Di Martino, M; Berloco, P; Passariello, R

Published Date

  • September 2008

Published In

Volume / Issue

  • 28 / 3

Start / End Page

  • 755 - 758

PubMed ID

  • 18777536

Pubmed Central ID

  • 18777536

Electronic International Standard Serial Number (EISSN)

  • 1522-2586

International Standard Serial Number (ISSN)

  • 1053-1807

Digital Object Identifier (DOI)

  • 10.1002/jmri.21519

Language

  • eng